Cargando…

PD-L1/PD-1 crosstalk in colorectal cancer: are we targeting the right cells?

BACKGROUND: The analysis of tumour-infiltrating immune cells within patients’ tumour samples in colorectal cancer (CRC) has become an independent predictor of patient survival. The tumour microenvironment and the immune checkpoints, such as PD-L1/PD-1, are relevant to the prognoses and also appear t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cantero-Cid, Ramón, Casas-Martin, José, Hernández-Jiménez, Enrique, Cubillos-Zapata, Carolina, Varela-Serrano, Aníbal, Avendaño-Ortiz, José, Casarrubios, Marta, Montalbán-Hernández, Karla, Villacañas-Gil, Ignacio, Guerra-Pastrián, Laura, Peinado, Begoña, Marcano, Cristóbal, Aguirre, Luis A, López-Collazo, Eduardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171318/ https://www.ncbi.nlm.nih.gov/pubmed/30285662 http://dx.doi.org/10.1186/s12885-018-4853-0

Ejemplares similares

Intertwined leukocyte balances in tumours and peripheral blood as robust predictors of right and left colorectal cancer survival
por: Cantero-Cid, Ramón, et al.
Publicado: (2022)

Soluble SIGLEC5: A New Prognosis Marker in Colorectal Cancer Patients
por: Montalbán-Hernández, Karla, et al.
Publicado: (2021)

Oxygen Saturation on Admission Is a Predictive Biomarker for PD-L1 Expression on Circulating Monocytes and Impaired Immune Response in Patients With Sepsis
por: Avendaño-Ortiz, José, et al.
Publicado: (2018)

Obstructive Sleep Apnea Monocytes Exhibit High Levels of Vascular Endothelial Growth Factor Secretion, Augmenting Tumor Progression
por: Cubillos-Zapata, Carolina, et al.
Publicado: (2018)

A System Dynamics Model to Predict the Human Monocyte Response to Endotoxins
por: Álvarez, Enrique, et al.
Publicado: (2017)

Galactomannan Downregulates the Inflammation Responses in Human Macrophages via NFκB2/p100
por: Toledano, Víctor, et al.
Publicado: (2015)

Soluble PD-L1: a potential immune marker for HIV-1 infection and virological failure
por: Avendaño-Ortiz, José, et al.
Publicado: (2020)

Colorectal Cancer Stem Cells Fuse with Monocytes to Form Tumour Hybrid Cells with the Ability to Migrate and Evade the Immune System
por: Montalbán-Hernández, Karla, et al.
Publicado: (2022)

Proteins from SARS-CoV-2 reduce T cell proliferation: A mirror image of sepsis
por: Avendaño-Ortiz, José, et al.
Publicado: (2020)

Potential Role of the Galectin-9/TIM-3 Axis in the Disparate Progression of SARS-CoV-2 in a Married Couple: A Case Report
por: Martín-Quirós, Alejandro, et al.
Publicado: (2021)

Expression of PD-1/PD-L1 and PD-L2 in peripheral T-cells from non-small cell lung cancer patients
por: Arrieta, Oscar, et al.
Publicado: (2017)

Understanding Inflammasomes and PD-1/PD-L1 Crosstalk to Improve Cancer Treatment Efficiency
por: Perrichet, Anaïs, et al.
Publicado: (2020)

mRNA-1273 boost after BNT162b2 vaccination generates comparable SARS-CoV-2-specific functional responses in naïve and COVID-19-recovered individuals
por: Lozano-Rodríguez, Roberto, et al.
Publicado: (2023)

Evaluation of a ConvitVax/anti-PD-1 combined immunotherapy for breast cancer treatment
por: Godoy-Calderón, María José, et al.
Publicado: (2019)

Crosstalk between HER2 and PD-1/PD-L1 in Breast Cancer: From Clinical Applications to Mathematical Models
por: Padmanabhan, Regina, et al.
Publicado: (2020)

Crosstalk Between PD-1/PD-L1 Blockade and Its Combinatorial Therapies in Tumor Immune Microenvironment: A Focus on HNSCC
por: Lin, Weimin, et al.
Publicado: (2018)

Identification of sSIGLEC5 and sLAG3 as New Relapse Predictors in Lung Cancer
por: Montalbán-Hernández, Karla, et al.
Publicado: (2022)

PD-L1 Expression in Systemic Immune Cell Populations as a Potential Predictive Biomarker of Responses to PD-L1/PD-1 Blockade Therapy in Lung Cancer
por: Bocanegra, Ana, et al.
Publicado: (2019)

Kinetic Study of Liquid-Phase Glycerol Hydrodeoxygenation into 1,2-Propanediol over CuPd/TiO(2)-Na
por: Ardila A, Alba N., et al.
Publicado: (2023)

Cellular and humoral functional responses after BNT162b2 mRNA vaccination differ longitudinally between naive and subjects recovered from COVID-19
por: Lozano-Rodríguez, Roberto, et al.
Publicado: (2022)

Voltage Oscillations in a Polymer Electrolyte Membrane Fuel Cell with Pd‐Pt/C and Pd/C Anodes
por: Nogueira, Jéssica Alves, et al.
Publicado: (2017)

Analysis of expression of the PD-1/PD-L1 immune checkpoint system and its prognostic impact in gastroenteropancreatic neuroendocrine tumors
por: Sampedro-Núñez, Miguel, et al.
Publicado: (2018)

Regulation of PD-1/PD-L1 pathway and resistance to PD-1/PD-L1 blockade
por: Bai, Jie, et al.
Publicado: (2017)

Prior SARS‐CoV‐2 infection balances immune responses triggered by four EMA‐approved COVID‐19 vaccines: An observational study
por: Lozano‐Rodríguez, Roberto, et al.
Publicado: (2022)

Differential Engraftment of Parental A20 PD-L1 WT and PD-L1 KO Leukemia Cells in Semiallogeneic Recipients in the Context of PD-L1/PD-1 Interaction and NK Cell-Mediated Hybrid Resistance
por: del Rio, Maria-Luisa, et al.
Publicado: (2022)

Immune Response and COVID-19: A mirror image of Sepsis
por: López-Collazo, Eduardo, et al.
Publicado: (2020)

Functional systemic CD4 immunity is required for clinical responses to PD‐L1/PD‐1 blockade therapy
por: Zuazo, Miren, et al.
Publicado: (2019)

Tumor stem cells fuse with monocytes to form highly invasive tumor-hybrid cells
por: Aguirre, Luis Augusto, et al.
Publicado: (2020)

ODP342 Panhypopituitarism Induced by CTLA-4 and PD-1/PD-L1 Inhibitor Immunotherapy
por: Hernandez-Cordero, Nicole, et al.
Publicado: (2022)

Noncanonical PD-1/PD-L1 Axis in Relation to the Efficacy of Anti-PD Therapy
por: Long, Yiru, et al.
Publicado: (2022)

The prognostic impact of SIGLEC5-induced impairment of CD8(+) T cell activation in sepsis
por: Lozano-Rodríguez, Roberto, et al.
Publicado: (2023)

Basis of PD1/PD-L1 Therapies
por: Seliger, Barbara
Publicado: (2019)

Therapeutic PD-L1 antibodies are more effective than PD-1 antibodies in blocking PD-1/PD-L1 signaling
por: De Sousa Linhares, Annika, et al.
Publicado: (2019)

Ceftobiprole: pharmacokinetics and PK/PD profile
por: Azanza Perea, José Ramón, et al.
Publicado: (2019)

Resistance to PD-L1/PD-1 Blockade Immunotherapy. A Tumor-Intrinsic or Tumor-Extrinsic Phenomenon?
por: Chocarro de Erauso, Luisa, et al.
Publicado: (2020)

Cover Feature: Voltage Oscillations in a Polymer Electrolyte Membrane Fuel Cell with Pd‐Pt/C and Pd/C Anodes (ChemistryOpen 5/2017)
por: Nogueira, Jéssica Alves, et al.
Publicado: (2017)

The immune checkpoints storm in COVID‐19: Role as severity markers at emergency department admission
por: Avendaño‐Ortiz, José, et al.
Publicado: (2021)

A novel [(89)Zr]-anti-PD-1-PET-CT to assess response to PD-1/PD-L1 blockade in lung cancer
por: Puyalto, Ander, et al.
Publicado: (2023)

Imaging of Dopamine in PD and Implications for Motor and Neuropsychiatric Manifestations of PD
por: de la Fuente-Fernández, Raúl
Publicado: (2013)

The Evolution of Pd(0)/Pd(II)-Catalyzed Aromatic Fluorination
por: Sather, Aaron C., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_eh8butj8kujrf2j8440lobsep9